Matteo Da Vià

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Luca Malcovati, Elli Papaemmanuil, David Bowen et al. · Blood · 2011 · 494 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma

Matteo Da Vià, Oliver Dietrich, Marietta Truger et al. · Nature Medicine · 2021 · 328 citations

Life Sciences, Immunology, Oncology +15

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia

Luca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio et al. · Blood · 2014 · 246 citations · Full text

Medicine, Genetics, Oncology +16

The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms

Luca Arcaini, Silvia Zibellini, Emanuela Boveri et al. · Blood · 2011 · 164 citations · Full text

Veterinary Medicine, Genetics, Oncology +14

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes

Matteo Giovanni Della Porta, Erica Travaglino, Emanuela Boveri et al. · Leukemia · 2014 · 148 citations · Full text

Medicine, Hematology, Pathology +17